Stocks and Investing Stocks and Investing
Mon, October 7, 2024
Fri, October 4, 2024

Jason Kolbert Maintained (TRVI) at Strong Buy and Held Target at $21 on, Oct 4th, 2024


Published on 2024-10-28 14:39:36 - WOPRAI, Jason Kolbert
  Print publication without navigation


Jason Kolbert of EF Hutton, Maintained "Trevi Therapeutics, Inc." (TRVI) at Strong Buy and Held Target at $21 on, Oct 4th, 2024.

Jason has made no other calls on TRVI in the last 4 months.



There are 4 other peers that have a rating on TRVI. Out of the 4 peers that are also analyzing TRVI, 0 agree with Jason's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Jason


  • Faisal Khurshid of "Leerink Partners" Initiated at Buy and Held Target at $7 on, Monday, September 9th, 2024
  • Oren Livnat of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $6 on, Friday, August 30th, 2024
  • Ryan Deschner of "Raymond James" Initiated at Buy and Held Target at $9 on, Friday, August 30th, 2024
  • Brandon Folkes of "Rodman & Renshaw" Initiated at Strong Buy and Held Target at $7 on, Thursday, June 13th, 2024

Contributing Sources